Researchers developing new approach for imaging dense breasts for abnormalities

January 24, 2014, The Geisel School of Medicine at Dartmouth
This photo shows an overview of the MRI/near-infrared spectroscopy (NIRS) system. The NIRS system is housed in the MRI control room (a) and light is piped into the MRI suite for patient imaging using fiber optic cables (b). A combined MRI/NIRS breast coil (c) makes simultaneous MRI and NIRS imaging possible. Credit: Photo courtesy of Norris Cotton Cancer Center

Dartmouth engineers and radiologists are developing new approaches for an emerging technique in diagnostic imaging for breast cancer—MRI with near-infrared spectroscopy (NIRS) as reported in the journal Academic Radiology, February 2014.

Combined MRI/NIRS may benefit women whose mammogram showed an abnormality and requires further testing to rule out cancer. The test would be conducted before an invasive biopsy to look for tumors. For the new method to work successfully in routine patient care, MRI/NIRS must adapt to an individual's body size as well as accommodate a range of cup sizes. The equipment must also mobilize and maintain contact with the .

An MRI/NIRS may offer specific advantages to women with , who are more likely to develop and die from . A dense breast is harder for a radiologist to "see through" when using traditional imaging equipment, which lacks the sensitivity to penetrate the dense tissue. Standard is effective 77-97 percent of the time in a normal breast, but when a breast is dense precision falls to 63-89 percent.

Prior approaches for MRI/NIRS used parallel plates and relied on custom breast molds for each patient. Biomedical engineers from the Thayer School of Engineering at Dartmouth developed a new, more flexible, convenient, and comfortable approach. They designed a set of eight light transmitting cables that can be adjusted to surround the breast with light tension. A woman lies on her stomach and the breast hangs pendant through the holes of the MRI/NIRS breast coil. The procedure is nearly identical to clinical MRI.

Eight women participated in a trial of the new design. "We found that the new interface allowed us to target lesions more effectively than ever before, said Michael Mastanduno, corresponding author of the study. "Set up time was faster and images were of higher quality."

The Dartmouth MRI/NIRS offers increased coverage of the chest, giving providers improved visibility for " hard to see" areas, such as the outside area of the breast near the armpit.

"This work is a huge improvement on previous designs of MRI/NIRS systems. All breast sizes and lesion locations can now be effectively imaged. Though there is more work to be done, this technology is promising for improving MRI's ability to distinguish cancer from benign abnormalities," said Mastanduno.

As a next step Dartmouth researchers will test MRI/NIRS in women with suspicious lesions.

Explore further: Preop MRI valuable in detecting additional malignancies in dense & not dense breasts

Related Stories

Preop MRI valuable in detecting additional malignancies in dense & not dense breasts

May 4, 2012
Newly diagnosed breast cancer patients should undergo a preoperative MRI exam even if their breasts are not dense, a new study indicates. The study found no difference between the usefulness of 3T breast MRI in detecting ...

Growing use of MRIs leading to more invasive breast cancer surgery

August 14, 2013
Heavy use of magnetic resonance imaging (MRI) may be leading to unnecessary breast removal in older women with breast cancer, according to a study by Yale School of Medicine researchers in the current issue of Breast Cancer ...

New breast cancer imaging technique could cut down on false positives

September 27, 2013
(Medical Xpress)—A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies.

MRI right before or after surgery does not benefit women with early breast cancer

September 4, 2013
Memorial Sloan-Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates. The findings ...

Two new studies on the use of breast MRI

November 18, 2013
The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study published by JAMA Internal Medicine.

Individualized breast cancer screening catches more cancer

August 12, 2013
(HealthDay)—A breast cancer screening program tailored to participants' individual risk profiles has a higher-than-expected breast cancer detection rate in 40- to 49-year old women, according to a pilot study published ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.